Paper6180609
Multi-enzyme-targeted chemotherapy by acivicin and actinomycin.
Weber G and 9 others. Adv Enzyme Regul, 1982. Cited by 51 papers, by iCite.
Cite this record
ConductScience Library. Multi-enzyme-targeted chemotherapy by acivicin and actinomycin. Papers, record 6180609. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6180609
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antimetabolites, Antineoplastic | Major topic |
| Dactinomycin | Major topic |
| Isoxazoles | Major topic |
| Liver Neoplasms, Experimental | Major topic |
| Oxazoles | Major topic |
| Sarcoma, Experimental | Major topic |
| Animals | |
| Cells, Cultured | |
| Deoxyribonucleotides | |
| Glutamine | |
| Humans | |
| Rats | |
| Rats, Inbred Strains | |
| Ribonucleotides |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| CA-05034 | NCI NIH HHS | United States | R01CA005034 | PubMed and NIH | NIH RePORTER |
| CA-13526 | NCI NIH HHS | United States | P01CA013526 | PubMed and NIH | NIH RePORTER |
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 51 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 38084059 | Targeting glutamine dependence with DRP-104 inhibits proliferation and tumor growth of castration-resistant prostate cancer. | Prostate | 2024 | https://conductscience.org/library/papers/38084059 | PubMed |
| 34530505 | Underlying mechanisms of phosphodiesterase 10A and glutamate-ammonia ligase genes that regulate inosine monophosphate deposition and thereby affect muscle tenderness in Jingyuan chickens. | Anim Biosci | 2022 | https://conductscience.org/library/papers/34530505 | PubMed |
| 28416670 | Alterations in cellular metabolism triggered by URA7 or GLN3 inactivation cause imbalanced dNTP pools and increased mutagenesis. | Proc Natl Acad Sci U S A | 2017 | https://conductscience.org/library/papers/28416670 | PubMed |
| 24047273 | Therapeutic strategies impacting cancer cell glutamine metabolism. | Future Med Chem | 2013 | https://conductscience.org/library/papers/24047273 | PubMed |
| 17103135 | The effects of removing the GAT domain from E. coli GMP synthetase. | Protein J | 2006 | https://conductscience.org/library/papers/17103135 | PubMed |
| 9065766 | Induction of nitric oxide synthesis in J774 cells lowers intracellular glutathione: effect of modulated glutathione redox status on nitric oxide synthase induction. | Biochem J | 1997 | https://conductscience.org/library/papers/9065766 | PubMed |
| 2347042 | Oncolytic activity and mechanism of action of a novel L-cysteine derivative, L-cysteine, ethyl ester, S-(N-methylcarbamate) monohydrochloride. | Cancer Chemother Pharmacol | 1990 | https://conductscience.org/library/papers/2347042 | PubMed |
| 1640933 | Relevance of glutamine metabolism to tumor cell growth. | Mol Cell Biochem | 1992 | https://conductscience.org/library/papers/1640933 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6180609
GET https://conductscience.org/api/papers/v1/6180609/authors